- Home
- IINN vs MIRA Comparison
IINN vs MIRA Comparison
Compare IINN & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- MIRA
- Stock Information
- Founded
- IINN 2018
- MIRA 2020
- Country
- IINN Israel
- MIRA United States
- Employees
- IINN N/A
- MIRA N/A
- Industry
- IINN Medical/Dental Instruments
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- IINN Health Care
- MIRA Health Care
- Exchange
- IINN Nasdaq
- MIRA Nasdaq
- Market Cap
- IINN 32.4M
- MIRA 33.7M
- IPO Year
- IINN 2021
- MIRA 2023
- Fundamental
- Price
- IINN $1.03
- MIRA $1.49
- Analyst Decision
- IINN Strong Buy
- MIRA
- Analyst Count
- IINN 1
- MIRA 0
- Target Price
- IINN $2.00
- MIRA N/A
- AVG Volume (30 Days)
- IINN 171.6K
- MIRA 286.8K
- Earning Date
- IINN 10-01-2025
- MIRA 11-13-2025
- Dividend Yield
- IINN N/A
- MIRA N/A
- EPS Growth
- IINN N/A
- MIRA N/A
- EPS
- IINN N/A
- MIRA N/A
- Revenue
- IINN $289,000.00
- MIRA N/A
- Revenue This Year
- IINN N/A
- MIRA N/A
- Revenue Next Year
- IINN $2,582.74
- MIRA N/A
- P/E Ratio
- IINN N/A
- MIRA N/A
- Revenue Growth
- IINN N/A
- MIRA N/A
- 52 Week Low
- IINN $0.40
- MIRA $0.73
- 52 Week High
- IINN $1.65
- MIRA $2.45
- Technical
- Relative Strength Index (RSI)
- IINN 54.28
- MIRA 52.64
- Support Level
- IINN $0.90
- MIRA $1.33
- Resistance Level
- IINN $1.00
- MIRA $1.45
- Average True Range (ATR)
- IINN 0.06
- MIRA 0.09
- MACD
- IINN 0.02
- MIRA -0.00
- Stochastic Oscillator
- IINN 96.77
- MIRA 79.63
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.